Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)

por Barratt, Jonathan, Rovin, Brad, Diva, Ulysses, Mercer, Alex, Komers, Radko
Publicado 2019

Implications of Complete Proteinuria Remission at any Time in Focal Segmental Glomerulosclerosis: Sparsentan DUET Trial

por Trachtman, Howard, Diva, Ulysses, Murphy, Edward, Wang, Kaijun, Inrig, Jula, Komers, Radko
Publicado 2023

Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis

por Komers, Radko, Diva, Ulysses, Inrig, Jula K., Loewen, Andrea, Trachtman, Howard, Rote, William E.
Publicado 2020